Andersen-Tawil syndrome: Clinical and molecular aspects

International Journal of Cardiology

Volumn 170, Issue 1, 2013, Pages 1-16

  Nguyen, Hoai Linh ^a   Pieper, Gerard H ^a   Wilders, Ronald ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Andersen Tawil syndrome; Cardiac ion channelopathies; Inward rectifier potassium channel; KCNJ2 gene; Kir2.1 protein

Indexed keywords

ACETAZOLAMIDE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DICLOFENAMIDE; FLECAINIDE; GLUCOCORTICOID; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR2.1; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE; PROPRANOLOL; VERAPAMIL;

AMINO ACID SUBSTITUTION; ANDERSEN SYNDROME; BINDING AFFINITY; CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA; CLINICAL FEATURE; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; DRUG MECHANISM; GAIN OF FUNCTION MUTATION; GENETIC SCREENING; HEART ARRHYTHMIA; HEART MUSCLE EXCITABILITY; HUMAN; KCNJ2 GENE; LONG QT SYNDROME; LOSS OF FUNCTION MUTATION; MOLECULAR MODEL; MUSCLE WEAKNESS; MUTATIONAL ANALYSIS; NEUROLOGIC DISEASE; NONHUMAN; PERIODIC PARALYSIS; POTASSIUM INTAKE; PRIORITY JOURNAL; QT INTERVAL; RARE DISEASE; REVIEW; TERATOLOGY;

AMINO ACID SEQUENCE; ANDERSEN SYNDROME; ANIMALS; HUMANS; MOLECULAR SEQUENCE DATA; MUTATION; POTASSIUM CHANNELS, INWARDLY RECTIFYING;

EID: 84888000558     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2013.10.010     Document Type: Review

References (184)

1. M. Tristani-Firouzi, J.L. Jensen, and M.R. Donaldson Functional and clinical characterization of KCNJ2 mutations associated with LQT7 (Andersen syndrome) J Clin Invest 110 2002 381 388
2. R. Klein, R. Ganelin, J.F. Marks, P. Usher, and C. Richards Periodic paralysis with cardiac arrhythmia J Pediatr 62 1963 371 385
3. E.D. Andersen, P.A. Krasilnikoff, and H. Overvad Intermittent muscular weakness, extrasystoles and multiple developmental anomalies. A new syndrome? Acta Paediatr Scand 60 1971 559 564
4. R. Tawil, L.J. Ptáček, and S.G. Pavlakis Andersen's syndrome: potassium-sensitive periodic paralysis, ventricular ectopy and dysmorphic features Ann Neurol 35 1994 326 330
5. L.P. Rowland Andersen's syndrome? Or Klein-Lisak-Andersen syndrome? Ann Neurol 36 1994 252 253
6. R. Tawil, L.J. Ptáček, and S.G. Pavlakis Andersen's syndrome? Or Klein-Lisak-Andersen syndrome? - reply Ann Neurol 36 1994 253
7. 2 binding residues of Kir2.1 are common targets of mutations causing Andersen syndrome Neurology 60 2003 1811 1816
8. D.H. Andersen Familial cirrhosis of the liver with storage of abnormal glycogen Lab Invest 5 1956 11 20
9. N.M. Plaster, R. Tawil, and M. Tristani-Firouzi Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Andersen's syndrome Cell 105 2001 511 519
10. M.R. Donaldson, G. Yoon, Y.H. Fu, and L.J. Ptacek Andersen-Tawil syndrome: a model of clinical variability, pleiotropy, and genetic heterogeneity Ann Med 36 Suppl. 1 2004 92 97
11. L. Zhang, D.W. Benson, and M. Tristani-Firouzi Electrocardiographic features in Andersen-Tawil syndrome patients with KCNJ2 mutations: characteristic T-U-wave patterns predict the KCNJ2 genotype Circulation 111 2005 272 276
12. Y. Haruna, A. Kobori, and T. Makiyama Genotype-phenotype correlations of KCNJ2 mutations in Japanese patients with Andersen-Tawil syndrome Hum Mutat 28 2007 208
13. S.P. Etheridge, N.E. Bowles, and C.B. Arrington Somatic mosaicism contributes to phenotypic variation in Timothy syndrome Am J Med Genet A 155 2011 2578 2583
14. S. Rajakulendran, S.V. Tan, and M.G. Hanna Muscle weakness, palpitations and a small chin: the Andersen-Tawil syndrome Pract Neurol 10 2010 227 231
15. E. Schulze-Bahr Long QT syndromes: genetic basis Card Electrophysiol Clin 4 2012 1 16
16. A. Horga, D.L. Raja Rayan, and E. Matthews Prevalence study of genetically defined skeletal muscle channelopathies in England Neurology 80 2013 1 4
17. G. Yoon, S. Oberoi, and M. Tristani-Firouzi Andersen-Tawil syndrome: prospective cohort analysis and expansion of the phenotype Am J Med Genet A 140 2006 312 321
18. P.M. Rautaharju, B. Surawicz, and L.S. Gettes AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram. Part IV: the ST segment, T and U waves, and the QT interval Circulation 119 2009 e241 e250
19. T.U.H. Chun, M.R. Epstein, and M. Dick II Polymorphic ventricular tachycardia and KCNJ2 mutations Heart Rhythm 1 2004 235 241
20. H. Kimura, J. Zhou, and M. Kawamura Phenotype variability in patients carrying KCNJ2 mutations Circ Cardiovasc Genet 5 2012 344 353
21. G. Andelfinger, A.R. Tapper, R.C. Welch, C.G. Vanoye, A.L. George Jr., and D.W. Benson KCNJ2 mutation results in Andersen syndrome with sex-specific cardiac and skeletal muscle phenotypes Am J Hum Genet 71 2002 663 668
22. M. Efremidis, L.K. Pappas, A. Sideris, K.P. Letsas, G.D. Gavrielatos, and F. Kardaras Swimming-triggered aborted sudden cardiac death in a patient with Andersen-Tawil syndrome Int J Cardiol 112 2006 e45 e47
23. S. Peters, E. Schulze-Bahr, S.P. Etheridge, and M. Tristani-Firouzi Sudden cardiac death in Andersen-Tawil syndrome Europace 9 2007 162 166
24. K.J. Airey, S.P. Etheridge, R. Tawil, and M. Tristani-Firouzi Resuscitated sudden cardiac death in Andersen-Tawil syndrome Heart Rhythm 6 2009 1814 1817
25. F. Sacher, I. Denjoy, and P. Dambrine Characterization of ventricular arrhythmias in Andersen-Tawil (long QT7) syndrome Heart Rhythm 3 Suppl. 2006 S322
26. J.Y. Pyo, D.H. Joh, and J.S. Park Ventricular tachyarrhythmias in a patient with Andersen-Tawil syndrome Korean Circ J 43 2013 62 65
27. G. Choi, L.J. Kopplin, D.J. Tester, M.L. Will, C.M. Haglund, and M.J. Ackerman Spectrum and frequency of cardiac channel defects in swimming-triggered arrhythmia syndromes Circulation 110 2004 2119 2124
28. B.A. Schoonderwoerd, A.C.P. Wiesfeld, and A.A.M. Wilde A family with Andersen-Tawil syndrome and dilated cardiomyopathy Heart Rhythm 3 2006 1346 1350
29. M. Tristani-Firouzi Andersen-Tawil syndrome: an ever-expanding phenotype? Heart Rhythm 3 2006 1351 1352
30. R.N. Subbiah, L.J. Gula, A.C. Skanes, and A.D. Krahn Andersen-Tawil syndrome: management challenges during pregnancy, labor, and delivery J Cardiovasc Electrophysiol 19 2008 987 989
31. C.A. Kamiya, W. Shimizu, and Y. Kabayashia Markedly reduced ventricular arrhythmia during the peripartum period in a pregnant woman with Andersen-Tawil syndrome J Arrhythm 28 2012 360 363
32. V. Sansone, R.C. Griggs, and G. Meola Andersen's syndrome: a distinct periodic paralysis Ann Neurol 42 1997 305 312
33. S. Canún, N. Pérez, and L.G. Beirana Andersen syndrome autosomal dominant in three generations Am J Med Genet 85 1999 147 156
34. G. Meola, M.G. Hanna, and B. Fontaine Diagnosis and new treatment in muscle channelopathies J Neurol Neurosurg Psychiatry 80 2009 360 365
35. R.A.P. Weir, C.J. Petrie, V. Murday, and I.N. Findlay Andersen-Tawil syndrome Int J Cardiol 148 2011 e13 e15
36. N.D. Child, J.C. Cleland, and R.H. Roxburgh Andersen-Tawil syndrome presenting as a fixed myopathy Muscle Nerve 48 2013 623
37. J.A. Burge, and M.G. Hanna Novel insights into the pathomechanisms of skeletal muscle channelopathies Curr Neurol Neurosci Rep 12 2012 62 69
38. D. Pillas, C.J. Hoggart, and D.M. Evans Genome-wide association study reveals multiple loci associated with primary tooth development during infancy PLoS Genet 6 2010 e1000856
39. N.P. Davies, P. Imbrici, and D. Fialho Andersen-Tawil syndrome: new potassium channel mutations and possible phenotypic variation Neurology 65 2005 1083 1089
40. K.F. Raab-Graham, C.M. Radeke, and C.A. Vandenberg Molecular cloning and expression of a human heart inward rectifier potassium channel Neuroreport 5 1994 2501 2505
41. S.V. Tan, W.J. Z'Graggen, and D. Boërio Membrane dysfunction in Andersen-Tawil syndrome assessed by velocity recovery cycles Muscle Nerve 46 2012 193 203
42. H.-F. Chan, M.-L. Chen, J.-J. Su, L.-C. Ko, C.-H. Lin, and R.-M. Wu A novel neuropsychiatric phenotype of KCNJ2 mutation in one Taiwanese family with Andersen-Tawil syndrome J Hum Genet 55 2010 186 188
43. D.L. Raja Rayan, S. Rajakulendran, and G. Barreto Genotype-phenotype correlation and longitudinal study of Andersen-Tawil Syndrome in the UK Neuromuscul Disord 21 Suppl. 1 2011 S14
44. E. Ciafaloni, S. Rajakulendran, and K.A. Hart Preliminary results of Andersen-Tawil syndrome genotype-phenotype longitudinal study from the Consortium for Clinical Investigation of Neurologic Channelopathies (CINCH) Neurology 76 Suppl. 4 2011 A645
45. E. Ciafaloni, S. Rajakulendran, and V. Sansone Preliminary results of Andersen-Tawil syndrome genotype-phenotype longitudinal study from the Consortium for Clinical Investigation of Neurologic Channelopathies (CINCH) Proceedings of the XXth World Congress on Neurology 2011 231
46. G. Yoon, L. Quitania, J.H. Kramer, Y.H. Fu, B.L. Miller, and L.J. Ptáček Andersen-Tawil syndrome: definition of a neurocognitive phenotype Neurology 66 2006 1703 1710
47. R.C.K. Chan, D. Shum, T. Toulopoulou, and E.Y.H. Chen Assessment of executive functions: review of instruments and identification of critical issues Arch Clin Neuropsychol 23 2008 201 216
48. V. Sansone, and R. Tawil Management and treatment of Andersen-Tawil syndrome (ATS) Neurotherapeutics 4 2007 233 237
49. S.L. Venance, S.C. Cannon, and D. Fialho The primary periodic paralyses: diagnosis, pathogenesis and treatment Brain 129 2006 8 17
50. P.G. McManis, E.H. Lambert, and J.R. Daube The exercise test in periodic paralysis Muscle Nerve 9 1986 704 710
51. J.S. Katz, G.I. Wolfe, S. Iannaccone, W.W. Bryan, and R.J. Barohn The exercise test in Andersen syndrome Arch Neurol 56 1999 352 356
52. T.T. Koopmann, M. Alders, and R.J. Jongbloed Long QT syndrome caused by a large duplication in the KCNH2 (HERG) gene undetectable by current polymerase chain reaction-based exon-scanning methodologies Heart Rhythm 3 2006 52 55
53. C.A. Eddy, J.M. MacCormick, and S.K. Chung Identification of large gene deletions and duplications in KCNQ1 and KCNH2 in patients with long QT syndrome Heart Rhythm 5 2008 1275 1281
54. A. Medeiros-Domingo, Z.A. Bhuiyan, and D.J. Tester The RYR2-encoded ryanodine receptor/calcium release channel in patients diagnosed previously with either catecholaminergic polymorphic ventricular tachycardia or genotype negative, exercise-induced long QT syndrome: a comprehensive open reading frame mutational analysis J Am Coll Cardiol 54 2009 2065 2074
55. D.J. Tester, A.J. Benton, L. Train, B. Deal, L.M. Baudhuin, and M.J. Ackerman Prevalence and spectrum of large deletions or duplications in the major long QT syndrome-susceptibility genes and implications for long QT syndrome genetic testing Am J Cardiol 106 2010 1124 1128
56. M.M. Medlock, D.J. Tester, M.L. Will, J.M. Bos, and M.J. Ackerman Repeat long QT syndrome genetic testing of phenotype-positive cases: prevalence and etiology of detection misses Heart Rhythm 9 2012 1977 1982
57. M.J. Ackerman, S.G. Priori, and S. Willems HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies Heart Rhythm 8 2011 1308 1339
58. D.J. Tester, P. Arya, and C.M. Haglund Genotypic heterogeneity and phenotypic mimicry among unrelated patients referred for catecholaminergic polymorphic ventricular tachycardia genetic testing Heart Rhythm 3 2006 800 805
59. H. Barajas-Martinez, D. Hu, and G. Ontiveros Biophysical and molecular characterization of a novel de novo KCNJ2 mutation associated with Andersen-Tawil syndrome and catecholaminergic polymorphic ventricular tachycardia mimicry Circ Cardiovasc Genet 4 2011 51 57
60. + channel gene KCNJ2 constitute a rare cause of long QT syndrome J Mol Cell Cardiol 37 2004 593 602
61. L.L. Eckhardt, A.L. Farley, and E. Rodriguez KCNJ2 mutations in arrhythmia patients referred for LQT testing: a mutation T305A with novel effect on rectification properties Heart Rhythm 4 2007 323 329
62. P.J. Schwartz, M. Stramba-Badiale, and L. Crotti Prevalence of the congenital long-QT syndrome Circulation 120 2009 1761 1767
63. IR2.x inward rectifier ion channel family: expression pattern and pathophysiology Acta Physiol 199 2010 243 256
64. N. Gaborit, S. Le Bouter, and V. Szuts Regional and tissue specific transcript signatures of ion channel genes in the non-diseased human heart J Physiol 582 2007 675 693
65. H. Hibino, A. Inanobe, K. Furutani, S. Murakami, I. Findlay, and Y. Kurachi Inwardly rectifying potassium channels: their structure, function, and physiological roles Physiol Rev 90 2010 291 366
66. H.J. Jongsma, and R. Wilders Channelopathies: Kir2.1 mutations jeopardize many cell functions Curr Biol 11 2001 R747 R750
67. L.Y. Ballester, D.W. Benson, and B. Wong Trafficking-competent and trafficking-defective KCNJ2 mutations in Andersen syndrome Hum Mutat 27 2006 388 395
68. P. Preisig-Müller, G. Schlichthörl, and G. Goerge Heteromerization of Kir2.x potassium channels contributes to the phenotype of Andersen's syndrome Proc Natl Acad Sci U S A 99 2002 7774 7779
69. K1) controls cardiac excitability and is involved in arrhythmogenesis Heart Rhythm 2 2005 316 324
70. J.M.B. Anumonwo, and A.N. Lopatin Cardiac strong inward rectifier potassium channels J Mol Cell Cardiol 48 2010 45 54
71. K1 modulates the U-wave: insights in a 100-year-old enigma Heart Rhythm 6 2009 393 400
72. D. Grob, R.J. Johns, and A. Liljestrand Potassium movement in patients with familial periodic paralysis: relationship to the defect in muscle function Am J Med 23 1957 356 375
73. K1 in a dominant-negative fashion Cardiovasc Res 59 2003 321 327
74. S. Bendahhou, E. Fournier, and D. Sternberg In vivo and in vitro functional characterization of Andersen's syndrome mutations J Physiol 565 2005 731 741
75. Y. Hosaka, H. Hanawa, and T. Washizuka Function, subcellular localization and assembly of a novel mutation of KCNJ2 in Andersen's syndrome J Mol Cell Cardiol 35 2003 409 415
76. S. Bendahhou, M.R. Donaldson, N.M. Plaster, M. Tristani-Firouzi, Y.H. Fu, and L.J. Ptácek Defective potassium channel Kir2.1 trafficking underlies Andersen-Tawil syndrome J Biol Chem 278 2003 51779 51785
77. M.M. Limberg, S. Zumhagen, and M.F. Netter Non dominant-negative KCNJ2 gene mutations leading to Andersen-Tawil syndrome with an isolated cardiac phenotype Basic Res Cardiol 108 2013 353
78. H. Morita, D.P. Zipes, S.T. Morita, and J. Wu Mechanism of U wave and polymorphic ventricular tachycardia in a canine tissue model of Andersen-Tawil syndrome Cardiovasc Res 75 2007 510 518
79. P.B. Radwański, R. Veeraraghavan, and S. Poelzing Cytosolic calcium accumulation and delayed repolarization associated with ventricular arrhythmias in a guinea pig model of Andersen-Tawil syndrome Heart Rhythm 7 2010 1428 1435
80. M. Maruyama, S.F. Lin, and P.S. Chen Alternans of diastolic intracellular calcium elevation as the mechanism of bidirectional ventricular tachycardia in a rabbit model of Andersen-Tawil syndrome Heart Rhythm 9 2012 626 627
81. M. Tsuboi, and C. Antzelevitch Cellular basis for electrocardiographic and arrhythmic manifestations of Andersen-Tawil syndrome (LQT7) Heart Rhythm 3 2006 328 335
82. K1 mutations in human left ventricular myocytes and tissue Am J Physiol Heart Circ Physiol 292 2007 H549 H559
83. K1: a simulation study Am J Physiol Heart Circ Physiol 291 2006 H2597 H2605
84. K.H.W.J. ten Tusscher, and A.V. Panfilov Alternans and spiral breakup in a human ventricular tissue model Am J Physiol Heart Circ Physiol 291 2006 H1088 H1100
85. P.B. Radwański, and S. Poelzing NCX is an important determinant for premature ventricular activity in a drug-induced model of Andersen-Tawil syndrome Cardiovasc Res 92 2011 57 66
86. K1 in the mouse heart leads to altered cardiac excitability J Mol Cell Cardiol 35 2003 367 378
87. C.W. Lu, J.H. Lin, and Y.S. Rajawat Functional and clinical characterization of a mutation in KCNJ2 associated with Andersen-Tawil syndrome J Med Genet 43 2006 653 659
88. K1) as revealed by the targeted deletion of the murine Kir2.1 and Kir2.2 genes J Physiol 533 2001 697 710
89. J. Miake, E. Marbán, and H.B. Nuss Biological pacemaker created by gene transfer Nature 419 2002 132 133
90. K1-downregulated human ventricular myocytes: insights from bifurcation analyses of a mathematical model Biophys J 89 2005 2865 2887
91. +-mediated vasodilation Circ Res 87 2000 160 166
92. + channel is required for patterning Development 139 2012 3653 3664
93. M.N. Obeyesekere, G.J. Klein, S. Conacher, and A.D. Krahn KCNJ2 variant of unknown significance reclassified as long QT syndrome causing ventricular fibrillation Can J Cardiol 27:870 2011 e11 e13
94. H. Wang, Y. Ma, and J. Huynh Functional characterization of KCNJ2 missense variants identified in patients with Andersen-Tawil Syndrome J Am Coll Cardiol 59 Suppl. 2012 E718
95. M. Šinkovec, A. Pernat, and M. Jan Novel KCNJ2 mutation associated with Andersen-Tawil syndrome Slov Med J 82 2013 55 60
96. E. Delannoy, F. Sacher, and P. Maury Cardiac characteristics and long-term outcome in Andersen-Tawil syndrome patients related to KCNJ2 mutation Europace 2013 http://dx.doi.org/10.1093/europace/eut160
97. 2 interactions underlie channelopathies Neuron 34 2002 933 944
98. 2 sensitivity in Andersen syndrome Channels (Austin) 1 2007 209 217
99. + conduction pathway J Biol Chem 282 2007 5781 5789
100. 2 binding to KCNJ2 (M307I) channels is linked to type 1 Andersen-Tawil syndrome Biophys J 104 Suppl. 1 2013 129a
101. 2) regulation of strong inward rectifier Kir2.1 channels: multilevel positive cooperativity J Physiol 586 2008 1833 1848
102. + channels Nat Rev Neurosci 4 2003 957 967
103. N. Decher, V. Renigunta, and M. Zuzarte Impaired interaction between the slide helix and the C-terminus of Kir2.1: a novel mechanism of Andersen syndrome Cardiovasc Res 75 2007 748 757
104. I. Takeda, T. Takahashi, and H. Ueno Autosomal recessive Andersen-Tawil syndrome with a novel mutation L94P in Kir2.1 Neurol Clin Neurosci 1 2013 131 137
105. S. Vergult, A. Dauber, and B. Delle Chiaie 17q24.2 microdeletions: a new syndromal entity with intellectual disability, truncal obesity, mood swings and hallucinations Eur J Hum Genet 20 2012 534 539
106. J.M. Lestner, R. Ellis, and N. Canham Delineating the 17q24.2-q24.3 microdeletion syndrome phenotype Eur J Med Genet 55 2012 700 704
107. A.V. Postma, Z.A. Bhuiyan, and M. Shkolnikova Involvement of the Kir2 gene family in catecholaminergic polymorphic ventricular tachycardia; analysis for mutations and identification of numerous pseudogenes Eur Heart J 25 Suppl. 1 2004 66
108. M. Kawamura, S. Ohno, and N. Naiki Genetic background of catecholaminergic polymorphic ventricular tachycardia in Japan Circ J 77 2013 1705 1713
109. A.L. Vega, D.J. Tester, M.J. Ackerman, and J.C. Makielski Protein kinase A-dependent biophysical phenotype for V227F-KCNJ2 mutation in catecholaminergic polymorphic ventricular tachycardia Circ Arrhythm Electrophysiol 2 2009 540 547
110. Y. Ruan, J. Theilade, and M. Memmi KCNJ2 mutations in patients referred for catecholaminergic polymorphic ventricular tachycardia gene screening Circulation 116 Suppl. 2007 II-492
111. Y. Ruan, L. Boveri, and T. Rossenbacker Arrhythmogenesis in mutant KCNJ2 associated catecholaminergic polymorphic ventricular tachycardia Circulation 118 Suppl. 2008 S-525
112. C.A. Remme, A.A.M. Wilde, and C.R. Bezzina Cardiac sodium channel overlap syndromes: different faces of SCN5A mutations Trends Cardiovasc Med 18 2008 78 87
113. M.V. Perez, M. Wheeler, M. Ho, A. Pavlovic, P. Wang, and E.A. Ashley Genetics of arrhythmia: disease pathways beyond ion channels J Cardiovasc Transl Res 1 2008 155 165
114. Z.A. Bhuiyan, M.A. Hamdan, and E.T. Shamsi A novel early onset lethal form of catecholaminergic polymorphic ventricular tachycardia maps to chromosome 7p14-p22 J Cardiovasc Electrophysiol 18 2007 1060 1066
115. 2 + cycling proteins and gene mutations Wien Med Wochenschr 162 2012 292 296
116. N. Roux-Buisson, M. Cacheux, and A. Fourest-Lieuvin Absence of triadin, a protein of the calcium release complex, is responsible for cardiac arrhythmia with sudden death in human Hum Mol Genet 21 2012 2759 2767
117. S.G. Priori, S.V. Pandit, and I. Rivolta A novel form of short QT syndrome (SQT3) is caused by a mutation in the KCNJ2 gene Circ Res 96 2005 800 807
118. T. Hattori, T. Makiyama, and M. Akao A novel gain-of-function KCNJ2 mutation associated with short-QT syndrome impairs inward rectification of Kir2.1 currents Cardiovasc Res 93 2012 666 673
119. M. Deo, Y. Ruan, and S.V. Pandit KCNJ2 mutation in short QT syndrome 3 results in atrial fibrillation and ventricular proarrhythmia Proc Natl Acad Sci U S A 110 2013 4291 4296
120. M. Xia, Q. Jin, and S. Bendahhou A Kir2.1 gain-of-function mutation underlies familial atrial fibrillation Biochem Biophys Res Commun 332 2005 1012 1019
121. E.C. Klaver, G.M. Versluijs, and R. Wilders Cardiac ion channel mutations in the sudden infant death syndrome Int J Cardiol 152 2011 162 170
122. J. Villafañe, J. Atallah, and M.H. Gollob Long-term follow-up of a pediatric cohort with short QT syndrome J Am Coll Cardiol 61 2013 1183 1191
123. S.E. Lehnart, M.J. Ackerman, and D.W. Benson Jr. Inherited arrhythmias: a National Heart, Lung, and Blood Institute and Office of Rare Diseases workshop consensus report about the diagnosis, phenotyping, molecular mechanisms, and therapeutic approaches for primary cardiomyopathies of gene mutations affecting ion channel function Circulation 116 2007 2325 2345
124. A.A.M. Wilde, and H.L. Tan Inherited arrhythmia syndromes Circ J 71 Suppl. A 2007 A12 A19
125. J.R. Giudicessi, and M.J. Ackerman Potassium-channel mutations and cardiac arrhythmias - diagnosis and therapy Nat Rev Cardiol 9 2012 319 332
126. K1 in the mouse heart leads to multiple abnormalities of cardiac excitability Am J Physiol Heart Circ Physiol 287 2004 H2790 H2802
127. G. Teodorescu Functional characterization of KCNJ2 mutations associated with Andersen-Tawil syndrome and atrial tachycardia PhD Thesis 2007 University of Ulm 14 15
128. P.J. Mohler, J.J. Schott, and A.O. Gramolini Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death Nature 421 2003 634 639
129. M. Vatta, M.J. Ackerman, and B. Ye Mutant caveolin-3 induces persistent late sodium current and is associated with long-QT syndrome Circulation 114 2006 2104 2112
130. L. Chen, M.L. Marquardt, D.J. Tester, K.J. Sampson, M.J. Ackerman, and R.S. Kass Mutation of an A-kinase-anchoring protein causes long-QT syndrome Proc Natl Acad Sci U S A 104 2007 20990 20995
131. K.L. Vikstrom, R. Vaidyanathan, and S. Levinsohn SAP97 regulates Kir2.3 channels by multiple mechanisms Am J Physiol Heart Circ Physiol 297 2009 H1387 H1397
132. K1) by synapse-associated protein-97 J Biol Chem 285 2010 28000 28009
133. D. Leonoudakis, L.R. Conti, C.M. Radeke, L.M.M. McGuire, and C.A. Vandenberg A multiprotein trafficking complex composed of SAP97, CASK, Veli, and Mint1 is associated with inward rectifier Kir2 potassium channels J Biol Chem 279 2004 19051 19063
134. G. Caruana, and A. Bernstein Craniofacial dysmorphogenesis including cleft palate in mice with an insertional mutation in the discs large gene Mol Cell Biol 21 2001 1475 1483
135. J.B. Wilson, M.W.J. Ferguson, N.A. Jenkins, L.F. Lock, N.G. Copeland, and A.J. Levine Transgenic mouse model of X-linked cleft palate Cell Growth Differ 4 1993 67 76
136. H.G. Laverty, and J.B. Wilson Murine CASK is disrupted in a sex-linked cleft palate mouse mutant Genomics 53 1998 29 41
137. R. Vaidyanathan, A.L. Vega, and C. Song The interaction of caveolin 3 protein with the potassium inward rectifier channel Kir2.1: physiology and pathology related to long QT syndrome 9 (LQT9) J Biol Chem 288 2013 17472 17480
138. J. Junker, W. Haverkamp, E. Schulze-Bahr, L. Eckhardt, W. Paulus, and R. Kiefer Amiodarone and acetazolamide for the treatment of genetically confirmed severe Andersen syndrome Neurology 59 2002 466
139. O.A. Pellizzon, L. Kalaizich, L.J. Ptáček, M. Tristani-Firouzi, and M.D. Gonzalez Flecainide suppresses bidirectional ventricular tachycardia and reverses tachycardia-induced cardiomyopathy in Andersen-Tawil syndrome J Cardiovasc Electrophysiol 19 2007 95 97
140. D.J. Fox, G.J. Klein, and A. Hahn Reduction of complex ventricular ectopy and improvement in exercise capacity with flecainide therapy in Andersen-Tawil syndrome Europace 10 2008 1006 1008
141. K. Miyamoto, H. Kimura, and H. Hayashi Suppression of ventricular arrhythmias with flecainide in patients with Andersen-Tawil syndrome with KCNJ2 mutation Europace 15 Suppl. 2 2013 ii145
142. D.S. Steele, H.S. Hwang, and B.C. Knollmann Triple mode of action of flecainide in catecholaminergic polymorphic ventricular tachycardia Cardiovasc Res 98 2013 326 327
143. + channels ameliorates arrhythmias in a drug-induced model of Andersen-Tawil syndrome Heart Rhythm 10 2013 255 263
144. H. Watanabe, N. Chopra, and D. Laver Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humans Nat Med 15 2009 380 383
145. R. Caballero, P. Dolz-Gaitón, and R. Gómez Flecainide increases Kir2.1 currents by interacting with cysteine 311, decreasing the polyamine-induced rectification Proc Natl Acad Sci U S A 107 2010 15631 15636
146. 2 activation of inward rectifier potassium (Kir2.1) channels J Gen Physiol 126 2005 541 549
147. P.J. Kannankeril, D.M. Roden, and F.A. Fish Suppression of bidirectional ventricular tachycardia and unmasking of prolonged QT interval with verapamil in Andersen's syndrome J Cardiovasc Electrophysiol 15 2004 119
148. O. Erdogan, A. Aksoy, N. Turgut, E. Durusoy, M. Samsa, and A. Altun Oral verapamil effectively suppressed complex ventricular arrhythmias and unmasked U waves in a patient with Andersen-Tawil syndrome J Electrocardiol 41 2008 325 328
149. N. Sumitomo, W. Shimizu, K. Taniguchi, and M. Hiraoka Calcium channel blocker and adenosine triphosphate terminate bidirectional ventricular tachycardia in a patient with Andersen-Tawil syndrome Heart Rhythm 5 2008 498 499
150. R. Bökenkamp, A.A. Wilde, M.J. Schalij, and N.A. Blom Flecainide for recurrent malignant ventricular arrhythmias in two siblings with Andersen-Tawil syndrome Heart Rhythm 4 2007 508 511
151. C. van der Werf, and A.A.M. Wilde Catecholaminergic polymorphic ventricular tachycardia: from bench to bedside Heart 99 2013 497 504
152. K. Airey, A. Wilde, and N. Hofman Incidence of device therapy and complications in patients with Andersen-Tawil syndrome with ICDs J Am Coll Cardiol 57 Suppl. 2011 E1233
153. +-deficient rats FASEB J 18 2004 760 761
154. D. Platt, and R.C. Griggs Use of acetazolamide in sulfonamide-allergic patients with neurologic channelopathies Arch Neurol 69 2012 527 529
155. D. Tricarico, and D.C. Camerino Recent advances in the pathogenesis and drug action in periodic paralyses and related channelopathies Front Pharmacol 2 2011 8
156. O.E. Osadchii Mechanisms of hypokalemia-induced ventricular arrhythmogenicity Fundam Clin Pharmacol 24 2010 547 559
157. e sensitivity Pflugers Arch 414 Suppl. 1 1989 S88 S92
158. G. Seebohm, N. Strutz-Seebohm, and O.N. Ursu Altered stress stimulation of inward rectifier potassium channels in Andersen-Tawil syndrome FASEB J 26 2012 513 522
159. P.J. Schwartz, L. Crotti, and R. Insolia Long-QT syndrome: from genetics to management Circ Arrhythm Electrophysiol 5 2012 868 877
160. I. Goldenberg, S. Horr, and A.J. Moss Risk for life-threatening cardiac events in patients with genotype-confirmed long-QT syndrome and normal-range corrected QT intervals J Am Coll Cardiol 57 2011 51 59
161. V. Sansone, G. Meola, T. Links, M. Panzeri, and M.R. Rose Treatment for periodic paralysis Cochrane Database Syst Rev 2006 CD005045
162. S. Bendahhou, E. Fournier, S. Gallet, D. Ménard, M.-M. Larroque, and J. Barhanin Corticosteroid-exacerbated symptoms in an Andersen's syndrome kindred Hum Mol Genet 16 2007 900 906
163. M. Arzel-Hézode, S. McGoey, D. Sternberg, S. Vicart, B. Eymard, and B. Fontaine Glucocorticoids may trigger attacks in several types of periodic paralysis Neuromuscul Disord 19 2009 217 219
164. S.B. Marrus, P.S. Cuculich, W. Wang, and J.M. Nerbonne Characterization of a novel, dominant negative KCNJ2 mutation associated with Andersen-Tawil syndrome Channels (Austin) 5 2011 500 509
165. 2 + sensitivity J Mol Cell Cardiol 43 2007 187 196
166. A. Garcia-Touchard, V.K. Somers, and T. Kara Ventricular ectopy during REM sleep: implications for nocturnal sudden cardiac death Nat Clin Pract Cardiovasc Med 4 2007 284 288
167. H. Itoh, W. Shimizu, and K. Hayashi Long QT syndrome with compound mutations is associated with a more severe phenotype: a Japanese multicenter study Heart Rhythm 7 2010 1411 1418
168. E. Fernlund, C. Lundin, E. Hertervig, O. Kongstad, M. Alders, and P. Platonov Novel mutation in the KCNJ2 gene is associated with a malignant arrhythmic phenotype of Andersen-Tawil syndrome Ann Noninvasive Electrocardiol 18 2013 471 478
169. B.C. Lim, G.B. Kim, and E.J. Bae Andersen cardiodysrhythmic periodic paralysis with KCNJ2 mutations: a novel mutation in the pore selectivity filter residue J Child Neurol 25 2010 490 493
170. A. Kobori, N. Sarai, and W. Shimizu Additional gene variants reduce effectiveness of beta-blockers in the LQT1 form of long QT syndrome J Cardiovasc Electrophysiol 15 2004 190 199
171. J.-B. Kim, and K.-W. Chung Novel de novo mutation in the KCNJ2 gene in a patient with Andersen-Tawil syndrome Pediatr Neurol 41 2009 464 466
172. S. Sacconi, D. Simkin, and N. Arrighi Mechanisms underlying Andersen's syndrome pathology in skeletal muscle are revealed in human myotubes Am J Physiol Cell Physiol 297 2009 C876 C885
173. T. Ai, Y. Fujiwara, and K. Tsuji Novel KCNJ2 mutation in familial periodic paralysis with ventricular dysarhythmia Circulation 105 2002 2592 2594
174. S. Nagase, K.F. Kusano, M. Yoshida, and T. Ohe Electrophysiologic characteristics of an Andersen syndrome patient with KCNJ2 mutation Heart Rhythm 4 2007 512 515
175. M. Nagashima, T. Higaki, Y. Seike, and Y. Yokoyama Cardiac surgery for a patient with Andersen-Tawil syndrome Ann Thorac Surg 90 2010 285 287
176. A. Modoni, M.L.E. Bianchi, and N. Vitulano Lack of any cardiac involvement in a patient with Andersen-Tawil syndrome associated with the c.574A → G mutation in KCNJ2 Cardiology 120 2011 200 203
177. B.-O. Choi, J. Kim, and B.C. Suh Mutations of KCNJ2 gene associated with Andersen-Tawil syndrome in Korean families J Hum Genet 52 2007 280 283
178. V.A. Sansone, C. Ricci, and M. Montanari Measuring quality of life impairment in skeletal muscle channelopathies Eur J Neurol 19 2012 1470 1476
179. T. Takahashi, S. Tandai, and T. Toki KCNJ2 mutation in intractable ventricular arrhythmia with Andersen's syndrome Pediatr Int 47 2005 220 223
180. C.H. Tengan, A.C. Antunes, J.R. Bauab, G.F. Prado, G.M. Manzano, and A.A. Gabbai Andersen syndrome: an association of periodic paralysis, cardiac arrhythmia and dysmorphic abnormalities Arq Neuropsiquiatr 64 2006 582 584
181. J. Díaz-Manera, L. Querol, J. Clarimón, S. Yagüe, and I. Illa Unique post-exercise electrophysiological test results in a new Andersen-Tawil syndrome mutation Clin Neurophysiol 122 2011 2537 2539
182. S. Tisma-Dupanovic, R. Gowdamarajan, I. Goldenberg, D.T. Huang, T. Knilans, and J.A. Towbin Prolonged QT in a 13-year-old patient with Down syndrome and complete atrioventricular canal defect Ann Noninvasive Electrocardiol 16 2011 403 406
183. Y. Kuramoto, Y. Furukawa, T. Yamada, Y. Okuyama, and M. Fukunami Andersen-Tawil syndrome associated with aborted sudden cardiac death: atrial pacing was effective for ventricular arrhythmias Am J Med Sci 344 2012 248 250
184. T. Doi, T. Makiyama, and T. Morimoto A novel KCNJ2 nonsense mutation, S369X, impedes trafficking and causes a limited form of Andersen-Tawil syndrome Circ Cardiovasc Genet 4 2011 253 260